152 related articles for article (PubMed ID: 11343737)
1. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P
Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737
[TBL] [Abstract][Full Text] [Related]
2. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
[TBL] [Abstract][Full Text] [Related]
3. [Effects of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): double-blind randomized trial].
Gnecchi M; Ardissino D
Ital Heart J Suppl; 2001 Sep; 2(9):1027-8. PubMed ID: 11675825
[No Abstract] [Full Text] [Related]
4. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
Koch W; Mehilli J; von Beckerath N; Böttiger C; Schömig A; Kastrati A
J Am Coll Cardiol; 2003 Jun; 41(11):1957-61. PubMed ID: 12798565
[TBL] [Abstract][Full Text] [Related]
6. Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention.
Toyofyuku M; Imazu M; Sumii K; Yamamoto H; Hayashi Y; Hiyama K; Kohno N
Atherosclerosis; 2002 Feb; 160(2):339-44. PubMed ID: 11849656
[TBL] [Abstract][Full Text] [Related]
7. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
[TBL] [Abstract][Full Text] [Related]
8. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting.
Gürlek A; Güleç S; Karabulut H; Bokesoy I; Tutar E; Pamir G; Alpman A; Toydemir R; Aras O; Oral D
J Cardiovasc Risk; 2000 Dec; 7(6):403-7. PubMed ID: 11155292
[TBL] [Abstract][Full Text] [Related]
9. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
[TBL] [Abstract][Full Text] [Related]
11. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
[TBL] [Abstract][Full Text] [Related]
12. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.
Ribichini F; Wijns W; Ferrero V; Matullo G; Camilla T; Feola M; Guarrera S; Vado A; Piazza A; Uslenghi E
Am J Cardiol; 2003 Jan; 91(2):154-8. PubMed ID: 12521626
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
[TBL] [Abstract][Full Text] [Related]
15. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis.
Ribichini F; Steffenino G; Dellavalle A; Matullo G; Colajanni E; Camilla T; Vado A; Benetton G; Uslenghi E; Piazza A
Circulation; 1998 Jan; 97(2):147-54. PubMed ID: 9445166
[TBL] [Abstract][Full Text] [Related]
16. Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound.
Kondo J; Sone T; Tsuboi H; Mukawa H; Kosokabe T; Tsuzuki M; Tomida T; Suzuki T; Kamiya H; Hayashi K; Matsui H; Okumura K
Am J Cardiol; 2001 Feb; 87(4):443-5, A6. PubMed ID: 11179530
[TBL] [Abstract][Full Text] [Related]
17. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
[TBL] [Abstract][Full Text] [Related]
18. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting.
Amant C; Bauters C; Bodart JC; Lablanche JM; Grollier G; Danchin N; Hamon M; Richard F; Helbecque N; McFadden EP; Amouyel P; Bertrand ME
Circulation; 1997 Jul; 96(1):56-60. PubMed ID: 9236417
[TBL] [Abstract][Full Text] [Related]
19. Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules.
Deftereos S; Giannopoulos G; Kossyvakis C; Kaoukis A; Raisakis K; Driva M; Panagopoulou V; Lappos S; Rentoukas I; Pyrgakis V; Alpert MA
Am J Cardiol; 2010 Jan; 105(1):54-8. PubMed ID: 20102890
[TBL] [Abstract][Full Text] [Related]
20. [D/D genotype of the gene for angiotensin converting enzyme as a risk factor for post-stent coronary restenosis].
Guarda E; Fajuri A; Marchant E; Martínez A; Jalil J; Illanes G; Vecchiola A; Lazen R; Flores A; Barra V; Irarrázabal S; Ilabaca F
Rev Esp Cardiol; 1999 Jul; 52(7):475-80. PubMed ID: 10439670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
